论文信息 - Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma - 字舞流文

Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma

K. Griffith | A. Jakubowiak | D. Reece | J. Zonder | A. Stefka | A. Kin | A. Major | J. Berdeja | B. Derman | J. Jasielec | C. Cole